Sign in

Neha Debnath

@nehadebnath.bsky.social
121 followers 360 following 2 posts

Nephrology fellow @StanfordNeph | Residency@MountSinaiNYC| Med-Ed @HarvardMacy #WomenInMedicine scholar.google.com/citations?user=3…

PostsRepliesMedia
Reposted by Neha Debnath
ISNkidneycare @theisn.org · 22/09/2025
Kidney health is gaining global attention. 🌐 As #UNGA tackles UHC & NCDs, the ISN-GKHA Interactive Map reveals/highlights: 📊 Access to dialysis & transplant 👩‍⚕️ Workforce gaps 💰 Health financing across countries Explore insights 👉 lite.spr.ly/6... #HLM4 #KidneyHealthMatters
042
Reposted by Neha Debnath
Duke Kidney @dukekidney.bsky.social · 22/09/2025
New ASN Kidney Translation Podcast hosted by Dr Sparks is out discussing the new ASN Kidney Health Guidance on Potassium and Phosphorus Food Additives with co-chairs Dr Biruete and Dr Kovesky 📰 here journals.lww.com/jas... 🎧 here
011
Reposted by Neha Debnath
NKF Nephrology Professionals @nkf-professionals.bsky.social · 22/09/2025
🩺 Considering transplant as a treatment? This course walks you through every step of the kidney transplant journey — from evaluation to post-transplant care. ✨ CE Credit Available 📚 Start learning: bit.ly/42yd3i9
011
Reposted by Neha Debnath
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 22/09/2025
As therapies in GN explode, the nephrology blogfather @kdjhaveri.bsky.social reviews the classes of drugs www.nephronpower.com/2025/09/in-n... #NephSky
nephronpower.com
In the News: B cell and plasma cell therapies in Glomerular Diseases
G lomerular diseases often result from loss of immune tolerance, leading to the production of autoantibodies by plasmablasts/plasma cells. B...
1112
Reposted by Neha Debnath
ASN Publications @asnpublications.bsky.social · 17/09/2025
Foot Process Effacement (FPE) could serve as a valuable marker for assessing the risk of disease progression across various kidney pathologies. Read more in #ASNKidney360: kidney.pub/KID0894 @ashunephro.bsky.social @sophieclaudel.bsky.social
062
Neha Debnath @nehadebnath.bsky.social · 16/09/2025
That’s a wrap for the 2025 ASN HDU course in Chicago! Invaluable learning experience for fellows and big steps ahead for PD, HHD, and access to Home Dialysis. #ASN #HDU #ASNEPC #PeritonealDialysis #Homedialysis @pd-perls.bsky.social
140
Reposted by Neha Debnath
NKF Nephrology Professionals @nkf-professionals.bsky.social · 16/09/2025
🚦 New CE course alert! Get a comprehensive overview of the kidney transplant journey—from evaluation to living donor vs. waitlist transplants. 🧠 Build your knowledge 📋 Support your patients 🎧 Start learning: bit.ly/42yd3i9
021
Reposted by Neha Debnath
Nephrology Journal Club @nephjc.bsky.social · 16/09/2025
❤️Check out the VA for the discussion on the AHA/ACC Hypertension Guidelines 9/16/25 at 9pm EST by @sejalplakhani.bsky.social #NephJC #NephSky #MedSky www.nephjc.com/news/2025/9/ahaacc-htnguide
nephjc.com
The AHA/ACC 2025 Hypertension Guidelines visual abstract — NephJC
New updated guidance on hypertension including screening for secondary causes, use of renal denervation, hypertension and pregnancy, risk assessment, monitoring and treatment. Check out this wonderfu...
01914
Reposted by Neha Debnath
Matthew Sparks @nephrosparks.bsky.social · 15/09/2025
Take a listen to all of the @asnpublications.bsky.social ASN Kidney Translation Kidney Podcast series here journals.lww.com/asnjournals/...
021
Reposted by Neha Debnath
grahamabra.bsky.social @grahamabra.bsky.social · 13/09/2025
Have hyperglycemia (and other DM badness) been hiding in plain sight in ESKD? Probably. Great study using CGMs in ESKD. Pts with treated DM, mean TIR only 43% while mean HbA1c was 7.0% journals.lww.com/jasn/abstrac...
journals.lww.com
Glycemia Assessed by Continuous Glucose Monitoring among... : Journal of the American Society of Nephrology
ilure and its treatments disrupt glucose homeostasis in ways that may promote both hyperglycemia and hypoglycemia. Continuous glucose monitoring (CGM) delineates detailed glycemic profiles, but publis...
3127